The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Adrian M. Di Bisceglie

Division of Gastroenterology and Hepatology

Saint Louis University School of Medicine

St. Louis

USA

[email]@slu.edu

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Division of Gastroenterology and Hepatology, Saint Louis University School of Medicine, St. Louis, USA. 2000 - 2011
  • Department of Internal Medicine, Saint Louis University, St Louis, USA. 2000 - 2010
  • Saint Louis University Liver Center, Department of Medicine, Saint Louis University, 3635 Vista Ave at Grand Blvd, USA. 2005

References

  1. Excess mortality in patients with advanced chronic hepatitis C treated with long-term peginterferon. Di Bisceglie, A.M., Stoddard, A.M., Dienstag, J.L., Shiffman, M.L., Seeff, L.B., Bonkovsky, H.L., Morishima, C., Wright, E.C., Snow, K.K., Lee, W.M., Fontana, R.J., Morgan, T.R., Ghany, M.G. Hepatology (2011) [Pubmed]
  2. HIV-HBV coinfection among South African patients receiving antiretroviral therapy. Di Bisceglie, A.M., Maskew, M., Schulze, D., Reyneke, A., McNamara, L., Firnhaber, C. Antivir. Ther. (Lond.) (2010) [Pubmed]
  3. Hepatitis B and hepatocellular carcinoma. Di Bisceglie, A.M. Hepatology (2009) [Pubmed]
  4. Prolonged therapy of advanced chronic hepatitis C with low-dose peginterferon. Di Bisceglie, A.M., Shiffman, M.L., Everson, G.T., Lindsay, K.L., Everhart, J.E., Wright, E.C., Lee, W.M., Lok, A.S., Bonkovsky, H.L., Morgan, T.R., Ghany, M.G., Morishima, C., Snow, K.K., Dienstag, J.L. N. Engl. J. Med. (2008) [Pubmed]
  5. Early virologic response after peginterferon alpha-2a plus ribavirin or peginterferon alpha-2b plus ribavirin treatment in patients with chronic hepatitis C. Di Bisceglie, A.M., Ghalib, R.H., Hamzeh, F.M., Rustgi, V.K. J. Viral Hepat. (2007) [Pubmed]
  6. The AASLD and public policy: coming in out of the cold. Di Bisceglie, A.M. Hepatology (2007) [Pubmed]
  7. Pharmacokinetics, pharmacodynamics, and hepatitis C viral kinetics during antiviral therapy: the null responder. Di Bisceglie, A.M., Fan, X., Chambers, T., Strinko, J. J. Med. Virol. (2006) [Pubmed]
  8. Spontaneous retroperitoneal and rectus muscle hemorrhage as a potentially lethal complication of cirrhosis. Di Bisceglie, A.M., Richart, J.M. Liver Int. (2006) [Pubmed]
  9. Chemoprevention of hepatocellular carcinoma: use of tamoxifen in an animal model of hepatocarcinogenesis. Di Bisceglie, A.M., Osmack, P., Brunt, E.M. J. Lab. Clin. Med. (2005) [Pubmed]
  10. Serum alpha-fetoprotein levels in patients with advanced hepatitis C: results from the HALT-C Trial. Di Bisceglie, A.M., Sterling, R.K., Chung, R.T., Everhart, J.E., Dienstag, J.L., Bonkovsky, H.L., Wright, E.C., Everson, G.T., Lindsay, K.L., Lok, A.S., Lee, W.M., Morgan, T.R., Ghany, M.G., Gretch, D.R. J. Hepatol. (2005) [Pubmed]
  11. Pretransplant treatments for hepatocellular carcinoma: do they improve outcomes?. Di Bisceglie, A.M. Liver Transpl. (2005) [Pubmed]
  12. Issues in screening and surveillance for hepatocellular carcinoma. Di Bisceglie, A.M. Gastroenterology (2004) [Pubmed]
  13. Long term follow up of bone mineral density in patients with primary biliary cirrhosis. Di Bisceglie, A.M., Loyet, M., Peters, M. Minerva Med. (2004) [Pubmed]
  14. Combination therapy for hepatitis B. Di Bisceglie, A.M. Gut (2002) [Pubmed]
  15. Epidemiology and clinical presentation of hepatocellular carcinoma. Di Bisceglie, A.M. J. Vasc. Interv. Radiol (2002) [Pubmed]
  16. Optimal therapy of hepatitis C. Di Bisceglie, A.M., Hoofnagle, J.H. Hepatology (2002) [Pubmed]
  17. SEN and sensibility: interactions between newly discovered and other hepatitis viruses?. Di Bisceglie, A.M. Lancet (2001) [Pubmed]
  18. Natural history of hepatitis C: its impact on clinical management. Di Bisceglie, A.M. Hepatology (2000) [Pubmed]
  19. Iron reduction as an adjuvant to interferon therapy in patients with chronic hepatitis C who have previously not responded to interferon: a multicenter, prospective, randomized, controlled trial. Di Bisceglie, A.M., Bonkovsky, H.L., Chopra, S., Flamm, S., Reddy, R.K., Grace, N., Killenberg, P., Hunt, C., Tamburro, C., Tavill, A.S., Ferguson, R., Krawitt, E., Banner, B., Bacon, B.R. Hepatology (2000) [Pubmed]
 
WikiGenes - Universities